Neuronetics, Inc.

STIM Healthcare Medical Devices

Neuronetics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $149.2 million, up 99.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.08%, EPS grew 66.7%, free cash flow grew 62.1% and total debt rose 10.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

1.89 0.06 −3.08%
Market cap
$148.6M
P/E
0.0×
Fwd P/E
−2.8×
Dividend yield
—
F-score
4/9
Altman Z
−3.48
Beneish M
−2.59
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
4 3 4 3

+8 more TTM periods

ROE
(114.52%) (131.16%) (134.39%) (218.46%)
ROA
(22.87%) (27.76%) (27.61%) (40.53%)
ROIC
(24.64%) (31.09%) (34.06%) (37.93%)
Return on Tangible Assets
(107.21%) (163.03%) (109.87%) (108.85%)
Average Days of Receivables
38.29 39.02 41.34 53.92
Free Cash Flow per Share
(0.15) (0.19) (0.32) (0.45)
Free Cash Flow
(11.22) (13.56) (21.17) (30.55)
Other line items

Show all line items

Columns are period end dates